203 related articles for article (PubMed ID: 15066355)
21. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
Howell LP; Gurusinghe S; Tabnak F; Sciortino S
Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
[TBL] [Abstract][Full Text] [Related]
22. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
Nygård M; Daltveit AK; Thoresen SO; Nygård JF
BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
[TBL] [Abstract][Full Text] [Related]
23. Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey.
Hewitt M; Devesa SS; Breen N
Prev Med; 2004 Aug; 39(2):270-8. PubMed ID: 15226035
[TBL] [Abstract][Full Text] [Related]
24. The need to incorporate routine cervical cancer counselling and screening in the management of women at the outpatient clinics in Nigeria.
Dim CC; Nwagha UI; Ezegwui HU; Dim NR
J Obstet Gynaecol; 2009 Nov; 29(8):754-6. PubMed ID: 19821672
[TBL] [Abstract][Full Text] [Related]
25. Awareness of breast and cervical cancer risk factors and screening behaviours among nurses in rural region of Turkey.
Yaren A; Ozkilinc G; Guler A; Oztop I
Eur J Cancer Care (Engl); 2008 May; 17(3):278-84. PubMed ID: 18419631
[TBL] [Abstract][Full Text] [Related]
26. Associations in breast and colon cancer screening behavior in women.
Carlos RC; Fendrick AM; Patterson SK; Bernstein SJ
Acad Radiol; 2005 Apr; 12(4):451-8. PubMed ID: 15831418
[TBL] [Abstract][Full Text] [Related]
27. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
28. Pap screening in a U.S. health plan.
Insinga RP; Glass AG; Rush BB
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):355-60. PubMed ID: 15006908
[TBL] [Abstract][Full Text] [Related]
29. Pap smear screening among women >/=40 years residing at the United States-Mexico border.
Wallace D; Hunter J; Papenfuss M; De Zapien JG; Denman C; Giuliano AR
Health Care Women Int; 2007 Oct; 28(9):799-816. PubMed ID: 17907008
[TBL] [Abstract][Full Text] [Related]
30. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan.
Sung HY; Kearney KA; Miller M; Kinney W; Sawaya GF; Hiatt RA
Cancer; 2000 May; 88(10):2283-9. PubMed ID: 10820350
[TBL] [Abstract][Full Text] [Related]
31. Correlates of intent to seek unnecessary pap tests among elderly women.
Zhang Y; Borders TF; Rohrer JE
Womens Health Issues; 2007; 17(6):351-9. PubMed ID: 17936642
[TBL] [Abstract][Full Text] [Related]
32. Is a history of trauma associated with a reduced likelihood of cervical cancer screening?
Farley M; Golding JM; Minkoff JR
J Fam Pract; 2002 Oct; 51(10):827-31. PubMed ID: 12401150
[TBL] [Abstract][Full Text] [Related]
33. Comparison of visual inspection and Papanicolau (PAP) smears for cervical cancer screening in Honduras: should PAP smears be abandoned?
Perkins RB; Langrish SM; Stern LJ; Figueroa J; Simon CJ
Trop Med Int Health; 2007 Sep; 12(9):1018-25. PubMed ID: 17875013
[TBL] [Abstract][Full Text] [Related]
34. Understanding barriers to cervical cancer screening among Hispanic women.
Watts L; Joseph N; Velazquez A; Gonzalez M; Munro E; Muzikansky A; Rauh-Hain JA; Del Carmen MG
Am J Obstet Gynecol; 2009 Aug; 201(2):199.e1-8. PubMed ID: 19646571
[TBL] [Abstract][Full Text] [Related]
35. Decreasing cervical cancer mortality in Mexico: effect of Papanicolaou coverage, birthrate, and the importance of diagnostic validity of cytology.
Lazcano-Ponce E; Palacio-Mejia LS; Allen-Leigh B; Yunes-Diaz E; Alonso P; Schiavon R; Hernandez-Avila M
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2808-17. PubMed ID: 18843027
[TBL] [Abstract][Full Text] [Related]
36. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening?
Carlos RC; Fendrick AM; Ellis J; Bernstein SJ
J Am Coll Radiol; 2004 Oct; 1(10):769-76. PubMed ID: 17411698
[TBL] [Abstract][Full Text] [Related]
37. Abnormal Pap screening among Mexican-American women: impediments to receiving and reporting follow-up care.
Hunt LM; de Voogd KB; Akana LL; Browner CH
Oncol Nurs Forum; 1998; 25(10):1743-9. PubMed ID: 9826840
[TBL] [Abstract][Full Text] [Related]
38. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
[TBL] [Abstract][Full Text] [Related]
39. Pap smear screening and invasive cervical cancer.
Brown RK; Barker WH
J Fam Pract; 1982 Nov; 15(5):875-9. PubMed ID: 7130915
[TBL] [Abstract][Full Text] [Related]
40. Trends in abnormal cancer screening results in the United States of America.
Yabroff KR; Freedman A; Brown ML; Ballard-Barbash R; McNeel T; Taplin S
J Med Screen; 2007; 14(2):67-72. PubMed ID: 17626704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
